IDEA Collider: Innovation & Asymmetric Learning in Pharma
IDEA Pharma, SAI MedPartners
60 episodes
1 month ago
IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.
All content for IDEA Collider: Innovation & Asymmetric Learning in Pharma is the property of IDEA Pharma, SAI MedPartners and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.
The Industrial Revolution of Drug Discovery with Dr. Michael Secora
IDEA Collider: Innovation & Asymmetric Learning in Pharma
51 minutes 36 seconds
2 years ago
The Industrial Revolution of Drug Discovery with Dr. Michael Secora
The speed of Recursion is remarkable in delivering a value proposition. Michael Secora, Chief Financial Officer at Recursion, expounds on data relatability, building various data sets, and leveraging data sets to build a next-generation biopharmaceutical company! Moreover, he shares tips on standing out amongst competitors and what differentiates Recursion from other AI discovery companies.
IDEA Collider: Innovation & Asymmetric Learning in Pharma
IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.